Last reviewed · How we verify

NCT05691062: TLIF

Titanium vs. PEEK Fusion Devices in 1 Level TLIF

ENROLLING BY INVITATION Phase 4 Last updated 24 June 2025
What this trial tests

Phase 4 trial testing Titanium Fusion Device in Spine Fusion in 80 participants. Enrolling by invitation.

Timeline
1 September 2024
Primary endpoint
11 January 2027
11 January 2028

Quick facts

Lead sponsorTwin Cities Spine Center
PhasePhase 4
StatusENROLLING BY INVITATION
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment80
Start date1 September 2024
Primary completion11 January 2027
Estimated completion11 January 2028
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Twin Cities Spine Center

Who can join

Adults 18 to 70, any sex, with Spine Fusion or Lumbar Spondylolisthesis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to evaluate and follow the clinical and radiographic outcomes of patients undergoing 1 level TLIF randomized to either a titanium or a PEEK spacer to 24 months after surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spine Fusion

Currently open trials in the same condition.

Other Twin Cities Spine Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05691062.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing